在急性冠状动脉综合征个体患者中权衡抗血栓药物的获益与出血风险。 - Suppr

Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndrome.

作者信息

Van de Werf Frans

出版信息

Circulation. 2010 Jan 5;121(1):5-7. doi: 10.1161/CIR.0b013e3181cd3d17. Epub 2009 Dec 21.

DOI:10.1161/CIR.0b013e3181cd3d17

PMID:20026787

Abstract

摘要

相似文献

Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndrome.

Circulation. 2010 Jan 5;121(1):5-7. doi: 10.1161/CIR.0b013e3181cd3d17. Epub 2009 Dec 21.

[Coronary angioplasty in acute coronary syndromes: adjuvant drug therapy and management of the bleeding risk due to antithrombotic agents].

G Ital Cardiol (Rome). 2010 Dec;11(12 Suppl 3):34S-42S.

The risk of iatrogenic bleeding in acute coronary syndromes and long-term mortality.

Curr Opin Cardiol. 2008 Jul;23(4):327-34. doi: 10.1097/HCO.0b013e3283021c5b.

[Bleeding risk related to combined aspirin and other antithrombotic drug use in patients with acute coronary syndrome: prevention and therapy strategies].

Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Dec;38(12):1057-9.

Tailored antithrombotic therapy for acute coronary syndromes.

Expert Rev Cardiovasc Ther. 2008 Aug;6(7):935-44. doi: 10.1586/14779072.6.7.935.

Current antithrombotic agents for acute coronary syndromes: focus on bleeding risk.

Int J Cardiol. 2013 Feb 10;163(1):5-18. doi: 10.1016/j.ijcard.2011.10.104. Epub 2011 Nov 17.

Incidence of bleeding in 'real-life' acute coronary syndrome patients treated with antithrombotic therapy.

Cardiology. 2008;111(1):41-6. doi: 10.1159/000113426. Epub 2008 Feb 1.

Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy.

Eur Heart J. 2013 Jun;34(22):1621-9. doi: 10.1093/eurheartj/eht013. Epub 2013 Feb 4.

Clinical implications and management of bleeding events in patients with acute coronary syndromes.

J Cardiovasc Med (Hagerstown). 2009 Sep;10(9):677-86. doi: 10.2459/JCM.0b013e3283299808.

The medical management of acute coronary syndromes and potential roles for new antithrombotic agents.

J Emerg Med. 2008 May;34(4):417-28. doi: 10.1016/j.jemermed.2007.08.058. Epub 2008 Jan 28.

引用本文的文献

Characterization of GPVI- or GPVI-CD39-Coated Nanoparticles and Their Impact on In Vitro Thrombus Formation.

Int J Mol Sci. 2021 Dec 21;23(1):11. doi: 10.3390/ijms23010011.

The crystal structure of the active domain of Anopheles anti-platelet protein, a powerful anti-coagulant, in complex with an antibody.

J Biol Chem. 2014 Jun 6;289(23):16303-12. doi: 10.1074/jbc.M114.564526. Epub 2014 Apr 24.

The bleeding risk score as a mortality predictor in patients with acute coronary syndrome.

Arq Bras Cardiol. 2013 Dec;101(6):511-8. doi: 10.5935/abc.20130223. Epub 2013 Nov 12.

Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics.

Anesth Analg. 2011 Apr;112(4):777-99. doi: 10.1213/ANE.0b013e31820e7e4f. Epub 2011 Mar 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndrome.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndrome.

作者信息

出版信息

相似文献

引用本文的文献